https://fiquiperu.org.pe/2025/08/18/modulador-alyftrek-aprobado-en-estados-unidos-reino-unido-union-europea-y-canada/ 2025-08-18T20:38:11+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/08/modulador.jpg https://fiquiperu.org.pe/2025/08/18/decreto-supremo-n-004-2025-sa-decreto-supremo-que-regula-lo-dispuesto-en-el-articulo-9-de-la-ley-n-29698-ley-que-declara-de-interes-nacional-y-preferente-atencion-el-tratamiento-de-perso/ 2025-08-18T20:58:58+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/08/DS-de-Ley-29698.jpeg https://fiquiperu.org.pe/2025/08/18/aprobacion-de-ley-31738-ley-que-modifica-la-ley-29698ley-que-declara-de-interes-nacional-y-preferente-atencion-el-tratamiento-de-personas-que-padecen-enfermedades-raras-o-huerfanas/ 2025-08-18T20:59:06+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/08/Ley-31738.jpeg https://fiquiperu.org.pe/2025/08/18/aprobacion-de-ley-de-enfermedades-raras-y-huerfanas-29698-ley-que-declara-de-interes-nacional-y-preferente-atencion-el-tratamiento-de-personas-que-padecen-enfermedades-raras-o-huerfanas/ 2025-08-18T20:59:12+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/08/Ley-29698.jpg https://fiquiperu.org.pe/2025/08/18/ets-publicada-por-ins-lumacaftor-ivacaftor-para-fibrosis-quistica-por-mutacion-homocigota-f508del-y-afectacion-pulmonar-leve-o-moderada-en-pacientes-pediatricos/ 2025-10-10T00:00:09+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/08/federacion-espanola-fibrosis-quistica-nuevos-datos-confirman-la-eficacia-del-medicamento-ivacaftor-y-su-combinacion-con-lumacaftor-frente-a-la-fibrosis-quistica.jpg https://fiquiperu.org.pe/2025/08/18/tamizaje-neonatal-aprobacion-de-ley-31975/ 2025-10-10T13:32:58+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/10/TC-DECLARO-ESTADO-DE-COSAS-INCONSTITUCIONAL.jpg https://fiquiperu.org.pe/2025/08/18/decreto-supremo-no-004-2019-que-aprueba-el-reglamento-de-la-ley-que-declara-de-interes-nacional-y-preferente-atencion-el-tratamiento-de-personas-que-padecen-enfermedades-raras-o-huerfanas-en-es/ 2025-10-10T13:36:15+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/08/Lley-28044.jpg https://fiquiperu.org.pe/2025/08/18/minsa-concreto-adquisicion-de-medicamento-de-alto-costo-para-mejorar-la-calidad-de-vida-de-pacientes-con-fibrosis-quistica/ 2025-10-10T13:39:19+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/08/1085466-minsa-concreto-adquisicion-de-medicamento-de-alto-costo-para-mejorar-la-calidad-de-vida-de-pacientes-con-fibrosis-quistica.jpeg https://fiquiperu.org.pe/2025/07/27/pacientes-con-fibrosis-quistica-reciben-por-primera-vez-de-manera-gratuita-medicamento-de-triple-terapia/ 2025-10-10T13:42:22+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/07/1085556-01-6.jpg https://fiquiperu.org.pe/2025/10/09/tc-declaro-estado-de-cosas-inconstitucional-la-falta-de-atencion-de-salud-de-las-personas-que-padecen-de-enfermedades-raras-y-huerfanas-en-el-peru-agosto-2025/ 2025-10-10T13:48:13+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/10/Enfermedades-raras-scaled-1.jpg https://fiquiperu.org.pe/en/2025/11/30/the-constitutional-court-declared-the-lack-of-healthcare-for-people-suffering-from-rare-and-orphan-diseases-in-peru-an-unconstitutional-state-of-affairs-august-2025/ 2025-11-30T19:32:42+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/10/Enfermedades-raras-scaled-1.jpg https://fiquiperu.org.pe/en/2025/11/30/newborn-screening-approval-of-law-31975/ 2025-11-30T19:35:29+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/10/TC-DECLARO-ESTADO-DE-COSAS-INCONSTITUCIONAL.jpg https://fiquiperu.org.pe/en/2025/11/30/ets-published-by-ins-lumacaftor-ivacaftor-for-cystic-fibrosis-due-to-homozygous-f508del-mutation-and-mild-or-moderate-pulmonary-involvement-in-pediatric-patients/ 2025-11-30T19:39:06+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/08/federacion-espanola-fibrosis-quistica-nuevos-datos-confirman-la-eficacia-del-medicamento-ivacaftor-y-su-combinacion-con-lumacaftor-frente-a-la-fibrosis-quistica.jpg https://fiquiperu.org.pe/en/2025/11/30/supreme-decree-no-004-2025-sa-supreme-decree-that-regulates-the-provisions-of-article-9-of-law-no-29698-law-that-declares-the-treatment-of-people-suffering-from-rare-or-orphan-diseases-to-be-of-na/ 2025-11-30T19:49:51+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/08/DS-de-Ley-29698.jpeg https://fiquiperu.org.pe/en/2025/11/30/supreme-decree-no-004-2019-approving-the-regulations-of-the-law-declaring-the-treatment-of-persons-suffering-from-rare-or-orphan-diseases-to-be-of-national-interest-and-preferential-attention-await/ 2025-11-30T20:05:03+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/08/Lley-28044.jpg https://fiquiperu.org.pe/en/2025/11/30/approval-of-law-31738-law-that-modifies-law-29698-law-that-declares-the-treatment-of-people-suffering-from-rare-or-orphan-diseases-to-be-of-national-interest-and-preferential-attention/ 2025-11-30T20:25:02+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/08/Ley-31738.jpeg https://fiquiperu.org.pe/en/2025/11/30/approval-of-law-29698-on-rare-and-orphan-diseases-law-that-declares-the-treatment-of-people-suffering-from-rare-or-orphan-diseases-to-be-of-national-interest-and-preferential-attention/ 2025-11-30T20:29:37+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/08/Ley-29698.jpg https://fiquiperu.org.pe/en/2025/11/30/alyftrek-modulator-approved-in-the-united-states-united-kingdom-european-union-and-canada/ 2025-11-30T20:31:35+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/08/modulador.jpg https://fiquiperu.org.pe/en/2025/11/30/minsa-finalized-the-acquisition-of-high-cost-medication-to-improve-the-quality-of-life-of-patients-with-cystic-fibrosis/ 2025-11-30T20:33:31+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/08/1085466-minsa-concreto-adquisicion-de-medicamento-de-alto-costo-para-mejorar-la-calidad-de-vida-de-pacientes-con-fibrosis-quistica.jpeg https://fiquiperu.org.pe/en/2025/11/30/cystic-fibrosis-patients-receive-triple-therapy-medication-free-of-charge-for-the-first-time/ 2025-11-30T20:36:30+00:00 https://fiquiperu.org.pe/wp-content/uploads/2025/07/1085556-01-6.jpg